MELISSA YUNG: Open Payments
NPI 1598755241 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$735 in 53 payments from 12 companies in 2025. Trend: 2023 $388 · 2024 $420 · 2025 $735
Food & beverage: $735
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $262 |
| Novo Nordisk Inc | 10 | $194 |
| GlaxoSmithKline, LLC. | 2 | $44 |
| Abbott Laboratories | 2 | $40 |
| Lilly USA, LLC | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| PFIZER INC. | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $23 |
Products named: Ozempic, UBRELVY, QULIPTA, Wegovy, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, VRAYLAR, AIRSUPRA.
Industry payments across GA — which companies pay providers there.
